Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Takeda to Develop Maverick Therapeutics Cancer T-Cell Engagement Platform

Takeda Pharmaceutical will develop Maverick Therapeutics’ platform designed to improve the utility of T-cell redirection therapy for cancer treatment ...

Forward this item to a colleague:


(Separate multiple addresses by commas)